| Johnson & Johnson Announces Collaboration with TIME to |
| @Marketwirenewstome |
07/16/2026 12:15:08 PM |
| I see$ JNJ looking at grabbing $ATAI... this |
| @Surendar |
07/15/2026 2:03:28 PM |
| The Race to Commercialize the Worlds Most Powerful Psychedelic |
| @kyle62637 |
07/15/2026 2:02:43 PM |
| Johnson & Johnson reports Q2 2026 results, raises |
| @daniel8774 |
07/15/2026 10:30:24 AM |
| Johnson & Johnson Announces Quarterly Dividend for Third |
| @nthyaga |
07/15/2026 10:30:02 AM |
| Psychedelics guidance from the FDA set to benefit |
| @mikemikemc |
07/13/2026 7:08:30 PM |
| JNJ Possible to be in talks with $ATAI... |
| @Ford |
07/13/2026 7:06:05 PM |
| Wall Street Set for Softer Open as Oil |
| @Sonic |
07/13/2026 1:30:50 PM |
| U.S. Futures Drift as Investors Await Earnings Season |
| @Huachen |
07/10/2026 1:45:39 PM |
| Johnson & Johnson Announces FDA Approval for the |
| @DerickoCooper |
07/08/2026 11:45:08 AM |
| Johnson & Johnson presents new IMAAVY (nipocalimab-aahu) data |
| @Lee |
06/26/2026 4:45:08 PM |
| New TALVEY (talquetamab-tgvs) plus DARZALEX FASPRO (daratumumab and |
| @Munna |
06/13/2026 10:45:01 AM |
| Johnson & Johnson Reports Strong Late-Stage Results for |
| @ac8c26f44abc6f068470e5a34e6528 |
06/11/2026 1:00:49 PM |
| Johnson & Johnson Expands U.S. Availability of TECNIS |
| @yaelkislev |
06/11/2026 12:02:01 PM |
| IMAAVY (nipocalimab-aahu) demonstrates durable hemoglobin response and rapid |
| @maojame |
06/11/2026 6:15:12 AM |
| Anyone seeing$ JNJ possibly buy any of the |
| @Foogle |
06/05/2026 4:52:57 PM |
| Johnson & Johnson presents new data further reinforcing |
| @Nehaambore |
06/03/2026 4:15:17 AM |
| Johnson & Johnson late-breaking results show nipocalimab significantly |
| @Barry1002 |
06/03/2026 4:15:07 AM |
| RYBREVANT FASPRO (amivantamab and hyaluronidase-lpuj) pivotal data show |
| @jakeskorz |
05/31/2026 12:45:01 PM |
| Johnson & Johnson's Phase 3 prostate cancer study |
| @Summer |
05/31/2026 12:30:07 PM |
| RYBREVANT (amivantamab-vmjw) plus LAZCLUZE (lazertinib) demonstrates prolonged |
| @ScottConrad |
05/29/2026 6:15:02 PM |
| New TECVAYLI (teclistamab-cqyv) data demonstrate superior progression-free and |
| @Orymonster |
05/29/2026 12:30:10 PM |
| FDA approves label expansion, cementing TREMFYA as the |
| @Jyoti |
05/28/2026 11:15:02 PM |
| Johnson & Johnson to Host Investor Conference Call |
| @tedmarshall |
05/27/2026 8:30:39 PM |
| DePuy Synthes secures exclusive NOVOSIS bone graft distribution |
| @twhite199 |
05/26/2026 1:30:51 PM |
| CNS Drug Delivery Technologies Are Reshaping Alzheimer's and |
| @Michael477 |
05/13/2026 1:00:19 PM |
| Johnson & Johnson Advances the Standard of Calcium |
| @mwntesting13 |
05/12/2026 12:00:13 PM |
| Johnson & Johnson to Participate in the Goldman |
| @wizard |
05/11/2026 8:46:06 PM |
| Johnson & Johnson study shows TREMFYA (guselkumab) is |
| @Shellsworld13 |
05/05/2026 12:16:32 PM |
| Johnson & Johnson investigational co-antibody therapy $JNJ-4804 shows |
| @Eli789 |
05/05/2026 12:16:00 PM |
| It's been good not sure how much more |
| @garywhitaker |
04/30/2026 2:32:23 PM |
| Johnson & Johnson to Participate in the Bernsteins |
| @Gaurav2092 |
04/27/2026 8:45:59 PM |
| FDA grants Priority Review for IMAAVY (nipocalimab-aahu) as |
| @tpathu50 |
04/27/2026 12:15:50 PM |
| $JNJ, buy the dip
|
| @Monksdream |
04/25/2026 9:20:01 PM |
| Johnson & Johnson to Acquire Atraverse Medical in |
| @5Bgsh |
04/24/2026 2:15:28 PM |
| Johnson & Johnsons IMAAVY Demonstrates Durable Disease Control |
| @Hougaard |
04/22/2026 1:00:08 PM |
| IMAAVY (nipocalimab-aahu) shows over two years of sustained |
| @TailwindsResearch |
04/22/2026 12:15:50 PM |
| Johnson & Johnson to Participate in the 2026 |
| @jecicasily |
04/21/2026 8:31:15 PM |
| Johnson & Johnson Showcases CARTO-Powered Innovation, Including Debut |
| @bashirkhan |
04/21/2026 12:01:13 PM |
| Who will $JNJ buy next to support their |
| @Fadi |
04/19/2026 12:37:24 AM |
| Johnson & Johnson Beats Q1 Expectations, Lifts 2026 |
| @pmcoulter |
04/14/2026 1:00:59 PM |
| Johnson & Johnson Announces 64th Consecutive Year of |
| @chores63 |
04/14/2026 10:30:32 AM |
| Johnson & Johnson reports Q1 2026 results, raises |
| @Yawpee247 |
04/14/2026 10:30:19 AM |
| Johnson & Johnson Showcases New Clinical Data for |
| @benchitone |
04/10/2026 12:16:54 PM |
| Johnson & Johnson introduces VARIPULSE Pro in Europe |
| @Jo1099 |
04/07/2026 2:30:39 PM |
| "bioweapon, tale of ralph baric & the spike |
| @Wagsvt2018 |
04/07/2026 2:05:45 AM |
| $JNJ "Johnson & Johnson recently did a recall |
| @Nexus70 |
04/04/2026 4:54:20 PM |
| $JNJ, buy the dip
|
| @Monksdream |
04/03/2026 8:11:46 PM |
| They were talking about COVID-19 back in 2015 |
| @hnekuee |
03/31/2026 1:46:47 PM |
| Royalty Pharma signs $500M co-development agreement with J&J |
| @cryptogoddess |
03/30/2026 12:46:00 PM |